PANCREAS GROUP.ORG LTD

What PANCREAS GROUP.ORG LTD does

PANCREAS GROUP.ORG LTD (operating as PancreasGroup.org) is a London-headquartered, non-profit international research collaborative that conducts global studies on outcomes and failure to rescue (FTR) in pancreatic surgery. Founded in 2019 and hosted at Royal Free London NHS Foundation Trust's HPB Surgery and Liver Transplantation department, the organization is led by a group of Chief Investigators based at Royal Free Hospital (UK), Cedars-Sinai Medical Center (USA), and King Faisal Specialist Hospital & Research Centre (Saudi Arabia). It serves hepato-pancreato-biliary (HPB) surgeons and academic clinical researchers worldwide, with a registered membership of 3,180 experts across 641 institutions in 389 cities and 81 countries.

The collaborative operates through two sequential research programs. PancreasGroup.org 1 was a multi-center snapshot study identifying morbidity, mortality, and modifiable predicting factors in pancreatic surgery; its results were presented at IHPBA 2022 in New York and published in the British Journal of Surgery. PancreasGroup.org 2, launched at E-AHPBA 2023 in Lyon with over 100 international participants, is a global web-based survey using a standardized case report form (CRF) to capture expert-rated hospital-level factors influencing FTR, with the goal of building a prediction model that combines PancreasGroup.org 1 outcomes data with PancreasGroup.org 2 survey data. Participation is voluntary and free, with PubMed-citable co-authorship on all resulting publications as the primary incentive.

The organization does not generate commercial revenue. It is funded implicitly through institutional support from its host (Royal Free Hospital) and partner societies (UCL, IHPBA, GBIHPBA, PSGBI, ISLS, EDS, ESSO, GLOBALSURG), and distributes its outputs through peer-reviewed publication and presentation at international HPB surgery conferences. There are no disclosed funding rounds, paying customers, or pricing models; the operating model is closer to an academic consortium than a venture-backable enterprise.

Name

PANCREAS GROUP.ORG LTD

Legal name

PancreasGroup.org

Website

https://pancreasgroup.org

Company type

Private

Founded year

2022

Operating status

Operating

Ownership category

akta.pro rank

Product category

Medical Research Collaborative

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Membership Organizations (8600), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Pancreaticobiliary Disorders (HLAKAEAG), Liver & GI Clinical Research (Trials Centers) (HLAKAEAL), Conference Proceedings & Research Reports Publishing (EDAGAFAL)

Keywords

• Pancreatic surgery research
• Clinical outcomes research
• Surgical collaborative studies
• Global health research
• Failure to rescue studies

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Research Collaboration Services: PancreasGroup.org operates as a non-profit international research collaborative focused on improving pancreatic surgery outcomes. The organization does not generate commercial revenue but operates through institutional partnerships and research collaborations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

PancreasGroup.org conducts global collaborative research on outcomes and failure to rescue (FTR) in pancreatic surgery. The organization runs sequential research studies (PancreasGroup.org 1 and PancreasGroup.org 2) through a global network of HPB surgeons, using web-based case report forms to collect data and publishing results in peer-reviewed journals such as the British Journal of Surgery. Participation is voluntary and incentivized through PubMed-citable co-authorship.

Product overview

PancreasGroup.org is a research collaborative organization comprising two sequential studies focused on pancreatic surgery outcomes. PancreasGroup.org 1 was a published collaborative snapshot study (British Journal of Surgery) analyzing clinical outcomes and identifying modifiable risk factors in pancreatic surgery. PancreasGroup.org 2 builds on this foundation as a global survey that studies hospital-level factors affecting failure-to-rescue rates, using a web-based case report form (CRF) for data collection from experts across countries of all human development index levels. The organization operates through an international network of Chief Investigators, Scientific Committee members, and Management Committee members, with its headquarters at Royal Free Hospital in London, UK.

Differentiator

Problem solved

Functional benefit

Products and services

• PancreasGroup.org 1 The first collaborative snapshot study on clinical outcomes in pancreatic surgery, published in the British Journal of Surgery (BJS), identifying true morbidity and mortality rates and modifiable predicting factors of outcome after pancreatic surgery. Targeted at international HPB surgeons and the global surgical research community.
• PancreasGroup.org 2 Survey A global web-based survey among experts in pancreatic surgery investigating hospital-level factors influencing failure-to-rescue (FTR) rates after pancreatic surgery. Designed to develop a prediction model for FTR and establish international collaborations for improving patient safety. Targeted at HPB surgery experts across countries of all HDI levels.
• Web-Based Case Report Form (CRF) A web-based case report form used for survey data submission in PancreasGroup.org 2, allowing experts to rate hospital-related factors based on their institutional experience regarding failure-to-rescue outcomes. Targeted at HPB surgery experts participating in the global collaborative research.

Quantifiable outcome

• Identified significant variations in failure-to-rescue (FTR) rates between countries of low/middle versus high/very high human development index (HDI) countries

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered core, major and supporting.

• UCL (University College London)coreStrategic or Co-development PartnerAffiliated institution providing academic support and research infrastructure. Royal Free Hospital is affiliated with UCL, serving as the headquarters for PancreasGroup.org.
• Royal Free Hospital NHS Foundation TrustcoreStrategic or Co-development PartnerPrimary institutional host for PancreasGroup.org headquarters. HPB Surgery and Liver Transplantation department provides leadership and administrative support for the collaborative.
• IHPBA (International Hepato-Pancreato-Biliary Association)coreStrategic or Co-development PartnerGlobal association for HPB surgery. PancreasGroup.org 1 results were presented at IHPBA 2022 in New York.
• GBIHPBA (Global Alliance for Improved HPB Surgery)coreStrategic or Co-development PartnerGlobal alliance focused on improving HPB surgery outcomes. Collaborating partner in the PancreasGroup.org initiative.
• PSGBI (Pancreatic Society of Great Britain and Ireland)majorStrategic or Co-development PartnerNational society for pancreatic surgery in the UK and Ireland. Partner organization supporting the research collaborative.
• EDS (Emergency Department Surgery)supportingStrategic or Co-development PartnerPartner organization in the PancreasGroup.org collaborative network.
• ISLS (International Society for Liver Surgery)supportingStrategic or Co-development PartnerInternational society for liver surgery participating in the collaborative network.
• GLOBALSURGmajorStrategic or Co-development PartnerGlobal surgical research network collaborating with PancreasGroup.org on improving surgical outcomes.
• ESSO (European Society of Surgical Oncology)supportingStrategic or Co-development PartnerEuropean society for surgical oncology participating in the collaborative network.
• King Faisal Specialist Hospital & Research CentremajorStrategic or Co-development PartnerOne of the Chief Investigators (Dr. Dimitri Raptis) is affiliated with this institution in Riyadh, Saudi Arabia, providing institutional support and leadership.
• Cedars-Sinai Medical CentermajorStrategic or Co-development PartnerChief Investigator Dr. Cristina Ferrone is affiliated with Cedars-Sinai Medical Center in Los Angeles, California, United States.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• STARSurg: UK-based student- and trainee-led collaborative conducting multi-center audit and research studies across surgical specialties, using shared CRF platforms and PubMed-indexed co-authorship incentives for participants.
• COVIDSurg Collaborative: International collaborative of surgeons conducting outcome studies using the GlobalSurg network framework; comparable in community-led, snapshot-study methodology and rapid multi-country data collection.
• Pancreatic Cancer Action Network (PanCAN): US-based patient advocacy and research organization focused on pancreatic cancer; shares the pancreatic disease focus but operates through advocacy, funding, and patient services rather than surgeon-led outcome studies.
• National Pancreas Foundation: US nonprofit dedicated to pancreatic disease research, education, and patient support; comparable in disease-specific non-profit structure and research orientation around pancreatic conditions.
• GlobalSurg Collaborative: Global surgical outcomes research network that runs international cohort studies and collaborative trials using similar web-based CRFs and co-authorship models; explicitly partnered with PancreasGroup.org and the most directly comparable peer in scale and methodology.

Others

• European Cancer Organisation (ECCO): Federation of European oncology societies, including ESSO, which partners with PancreasGroup.org; adjacent ecosystem participant that shapes cancer research policy and convenes relevant clinical communities.
• NIHR Global Health Research: UK funder of global health research programs and infrastructure; adjacent enabler that often co-funds the type of capacity-building, LMIC-focused surgical outcomes research PancreasGroup.org conducts.

Emerging players

• IDEAL Collaboration: International framework for evaluating surgical innovation through staged prospective studies; overlaps thematically on improving surgical evidence generation but is methodology-focused rather than disease-specific.

Broad incumbents

• International Hepato-Pancreato-Biliary Association (IHPBA): Global professional society governing HPB surgery practice and research; a strategic partner of PancreasGroup.org and the broader umbrella organization for the field in which the collaborative operates.
• American College of Surgeons NSQIP: Large-scale, established surgical quality and outcomes registry that prospectively collects perioperative data across hundreds of US hospitals; comparable in measuring surgical outcomes and FTR-type metrics but at much larger institutional scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PANCREAS GROUP.ORG LTD